Radiomics Quality Score 2.0: towards radiomics readiness levels and clinical translation for personalized medicine
8.5
来源：
Nature
关键字：
deep learning brain science
资金机构：
European Union; Guangzhou basic and applied basic research foundation; Dutch Cancer Society; NIH
发布时间：
2025-09-03 22:23
摘要：
Radiomics Quality Score 2.0 introduces an updated framework to enhance the quality and clinical translation of radiomics studies in precision oncology. It addresses previous limitations by incorporating new criteria and readiness levels, aiming to improve methodological rigor and facilitate the integration of radiomics into clinical practice. This initiative is expected to drive advancements in cancer diagnosis and treatment response prediction, ultimately benefiting patient care.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0
business_impact
1.0
scientific_rigor
1.5
timeliness_innovation
1.5
investment_perspective
2.5
market_value_relevance
1.0
team_institution_background
0.5
technical_barrier_competition
0.5
关键证据
Radiomics is a tool for medical imaging analysis that could have a relevant role in precision oncology.
The updated RQS 2.0 addresses contemporary needs and could potentially accelerate clinical translation.
Key barriers to clinical translation of radiomics include methodological inconsistencies and lack of transparency.
真实性检查
否
AI评分总结
Radiomics Quality Score 2.0 introduces an updated framework to enhance the quality and clinical translation of radiomics studies in precision oncology. It addresses previous limitations by incorporating new criteria and readiness levels, aiming to improve methodological rigor and facilitate the integration of radiomics into clinical practice. This initiative is expected to drive advancements in cancer diagnosis and treatment response prediction, ultimately benefiting patient care.